HOSPITAL UNIVERSITARIO DE GETAFE
Departamento
Universidad de Málaga
Málaga, EspañaPublicaciones en colaboración con investigadores/as de Universidad de Málaga (3)
2024
-
Real-world safety and effectiveness of dapagliflozin in people living with type 1 diabetes in Spain: The Dapa-ON multicenter retrospective study
Diabetes and Metabolism, Vol. 50, Núm. 1
2023
-
Evaluation of the Clinical Impact of Dapagliflozin Discontinuation as Adjunctive Therapy for Patients With Type 1 Diabetes After Indication Withdrawal: A Two-Center Retrospective Study
Diabetes care, Vol. 46, Núm. 5, pp. e101-e102
2009
-
High-activity variants of the uMAOA polymorphism increase the risk for depression in a large primary care sample
American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, Vol. 150, Núm. 3, pp. 395-402